Price: $572.2
· 1 day: +1.56% · 5 days: +1.17% · 1 month: +6.36% · YTD: +6.40%
As of 2026-10-09 15:30 UTC.
52-week range: $454.6 – $597.8 (currently at 82% of the range).
The read
LONN.SW is in an uptrend, momentum firm. $580.4 is the level overhead; $567.17 the first support below.
6 of 6 technical checks lean bullish.
Price vs 50-day: above
Price vs 200-day: above
50d vs 200d avg: above
MACD: bullish
RSI momentum: 61
5-day tape: +1.2%
Trend
Uptrend · above 50-day & 200-day
Momentum
RSI 61.49 · neutral · MACD bullish
Trend strength
ADX 15.0 · weak or range
Location
+0.9% vs 50-day MA
52-week range
-4% from high · +23% from low
Volatility
ATR 13.46 · ~2.4%/day
Key levels
Level
Type
Distance
$580.4 (resistance)
swing zone
1.43%
$593.8 (resistance)
52w high
3.77%
$600.0 (resistance)
round
4.86%
$567.17 (support)
sma 50
-0.88%
$554.6 (support)
swing zone
-3.08%
$550.0 (support)
round
-3.88%
Indicators
RSI (14)
61.49
MACD
2.9266
ADX (14)
15.0
ATR (14)
13.46
50-day average
$567.17
200-day average
$532.37
Next earnings: 2026-01-28.
Latest LONN.SW news
Health Care Roundup: Market Talk — ```json
{
"summary": "Sanofi requires mergers and acquisitions to replenish its late-stage drug pipeline, according to market commentary published on Dow Jones Newswires. The pharmaceutical company faces challenges in (The Wall Street Journal, 2026-10-06)
Lonza to Expand U.S. Manufacturing Footprint With New Oregon Site — Lonza Group announced plans to expand its U.S. manufacturing footprint with a new facility in Bend, Oregon, targeting growing domestic demand and more resilient pharmaceutical supply chains. The Swiss contract drug manuf (Morningstar, 2026-09-10)
WuXi AppTec's 100% Stock Rally Defies Geopolitical Headwinds — WuXi AppTec's stock has rallied approximately 100% despite being designated as a Chinese military company by the Pentagon, a move that has led some U.S. clients to reduce their business with the firm. Investors are conti (Bloomberg Business, 2026-08-16)
Inside Operation Warp Speed's $18 Billion Sprint for a Vaccine — # Summary
Operation Warp Speed, the U.S. government's vaccine development initiative, mobilized an $18 billion investment to accelerate COVID-19 vaccine production and distribution. The program coordinated manufacturing (Bloomberg Business, 2026-06-13)